| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2012-09-06 21:02:40 UTC |
|---|
| Update Date | 2021-09-14 15:45:45 UTC |
|---|
| HMDB ID | HMDB0028832 |
|---|
| Secondary Accession Numbers | - HMDB0059717
- HMDB28832
- HMDB59717
|
|---|
| Metabolite Identification |
|---|
| Common Name | Glutamylvaline |
|---|
| Description | Glutamylvaline is a dipeptide composed of glutamate and valine, and is a proteolytic breakdown product of larger proteins. It belongs to the family of N-acyl-alpha amino acids and derivatives. These are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. Glutamylvaline is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. It is found in urine (PMID: 3782411 ). |
|---|
| Structure | CC(C)[C@H](NC(=O)[C@@H](N)CCC(O)=O)C(O)=O InChI=1S/C10H18N2O5/c1-5(2)8(10(16)17)12-9(15)6(11)3-4-7(13)14/h5-6,8H,3-4,11H2,1-2H3,(H,12,15)(H,13,14)(H,16,17)/t6-,8-/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| alpha-Glu-val | ChEBI | | Glutamyl-valine | ChEBI | | L-alpha-Glu-L-val | ChEBI | | L-Glu-L-val | ChEBI | | L-Glutamyl-L-valine | ChEBI | | a-Glu-val | Generator | | Α-glu-val | Generator | | L-a-Glu-L-val | Generator | | L-Α-glu-L-val | Generator | | Α-L-glu-L-val | HMDB | | Α-glutamylvaline | HMDB | | Α-L-glutamyl-L-valine | HMDB | | L-Α-glutamyl-L-valine | HMDB | | N-Α-glutamylvaline | HMDB | | N-Α-L-glutamyl-L-valine | HMDB | | N-L-Α-glutamylvaline | HMDB | | N-L-Α-glutamyl-L-valine | HMDB | | alpha-L-Glu-L-val | HMDB | | alpha-Glutamylvaline | HMDB | | alpha-L-Glutamyl-L-valine | HMDB | | L-alpha-Glutamyl-L-valine | HMDB | | N-alpha-Glutamylvaline | HMDB | | N-alpha-L-Glutamyl-L-valine | HMDB | | N-L-alpha-Glutamylvaline | HMDB | | N-L-alpha-Glutamyl-L-valine | HMDB | | NSC 334345 | HMDB | | Glu-val | HMDB | | N-Glutamylvaline | HMDB | | N-L-Glutamyl-L-valine | HMDB | | Glutamic acid valine dipeptide | HMDB | | Glutamate valine dipeptide | HMDB | | Glutamic acid-valine dipeptide | HMDB | | Glutamate-valine dipeptide | HMDB | | e-V Dipeptide | HMDB | | EV dipeptide | HMDB | | Glutamylvaline | HMDB, ChEBI |
|
|---|
| Chemical Formula | C10H18N2O5 |
|---|
| Average Molecular Weight | 246.2603 |
|---|
| Monoisotopic Molecular Weight | 246.121571696 |
|---|
| IUPAC Name | (4S)-4-amino-4-{[(1S)-1-carboxy-2-methylpropyl]carbamoyl}butanoic acid |
|---|
| Traditional Name | (4S)-4-amino-4-{[(1S)-1-carboxy-2-methylpropyl]carbamoyl}butanoic acid |
|---|
| CAS Registry Number | 5879-06-1 |
|---|
| SMILES | CC(C)[C@H](NC(=O)[C@@H](N)CCC(O)=O)C(O)=O |
|---|
| InChI Identifier | InChI=1S/C10H18N2O5/c1-5(2)8(10(16)17)12-9(15)6(11)3-4-7(13)14/h5-6,8H,3-4,11H2,1-2H3,(H,12,15)(H,13,14)(H,16,17)/t6-,8-/m0/s1 |
|---|
| InChI Key | SITLTJHOQZFJGG-XPUUQOCRSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic acids and derivatives |
|---|
| Class | Carboxylic acids and derivatives |
|---|
| Sub Class | Amino acids, peptides, and analogues |
|---|
| Direct Parent | Dipeptides |
|---|
| Alternative Parents | |
|---|
| Substituents | - Alpha-dipeptide
- Glutamic acid or derivatives
- N-acyl-alpha-amino acid
- Valine or derivatives
- N-acyl-alpha amino acid or derivatives
- N-acyl-l-alpha-amino acid
- Alpha-amino acid amide
- Alpha-amino acid or derivatives
- Amino fatty acid
- Branched fatty acid
- Methyl-branched fatty acid
- Fatty amide
- N-acyl-amine
- Dicarboxylic acid or derivatives
- Fatty acyl
- Fatty acid
- Carboxamide group
- Secondary carboxylic acid amide
- Amino acid
- Amino acid or derivatives
- Carboxylic acid
- Organic nitrogen compound
- Primary aliphatic amine
- Organonitrogen compound
- Organooxygen compound
- Primary amine
- Carbonyl group
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Amine
- Organic oxygen compound
- Aliphatic acyclic compound
|
|---|
| Molecular Framework | Aliphatic acyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | -3.08 | Extrapolated |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 1.37 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 9.8938 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 8.35 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 320.6 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Glutamylvaline,1TMS,isomer #1 | CC(C)[C@H](NC(=O)[C@@H](N)CCC(=O)O[Si](C)(C)C)C(=O)O | 2107.8 | Semi standard non polar | 33892256 | | Glutamylvaline,1TMS,isomer #2 | CC(C)[C@H](NC(=O)[C@@H](N)CCC(=O)O)C(=O)O[Si](C)(C)C | 2101.4 | Semi standard non polar | 33892256 | | Glutamylvaline,1TMS,isomer #3 | CC(C)[C@H](NC(=O)[C@H](CCC(=O)O)N[Si](C)(C)C)C(=O)O | 2142.5 | Semi standard non polar | 33892256 | | Glutamylvaline,1TMS,isomer #4 | CC(C)[C@@H](C(=O)O)N(C(=O)[C@@H](N)CCC(=O)O)[Si](C)(C)C | 2054.7 | Semi standard non polar | 33892256 | | Glutamylvaline,2TMS,isomer #1 | CC(C)[C@H](NC(=O)[C@@H](N)CCC(=O)O[Si](C)(C)C)C(=O)O[Si](C)(C)C | 2123.0 | Semi standard non polar | 33892256 | | Glutamylvaline,2TMS,isomer #2 | CC(C)[C@H](NC(=O)[C@H](CCC(=O)O[Si](C)(C)C)N[Si](C)(C)C)C(=O)O | 2165.8 | Semi standard non polar | 33892256 | | Glutamylvaline,2TMS,isomer #3 | CC(C)[C@@H](C(=O)O)N(C(=O)[C@@H](N)CCC(=O)O[Si](C)(C)C)[Si](C)(C)C | 2044.8 | Semi standard non polar | 33892256 | | Glutamylvaline,2TMS,isomer #4 | CC(C)[C@H](NC(=O)[C@H](CCC(=O)O)N[Si](C)(C)C)C(=O)O[Si](C)(C)C | 2167.8 | Semi standard non polar | 33892256 | | Glutamylvaline,2TMS,isomer #5 | CC(C)[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)[C@@H](N)CCC(=O)O)[Si](C)(C)C | 2075.3 | Semi standard non polar | 33892256 | | Glutamylvaline,2TMS,isomer #6 | CC(C)[C@@H](C(=O)O)N(C(=O)[C@H](CCC(=O)O)N[Si](C)(C)C)[Si](C)(C)C | 2135.0 | Semi standard non polar | 33892256 | | Glutamylvaline,2TMS,isomer #7 | CC(C)[C@H](NC(=O)[C@H](CCC(=O)O)N([Si](C)(C)C)[Si](C)(C)C)C(=O)O | 2287.7 | Semi standard non polar | 33892256 | | Glutamylvaline,3TMS,isomer #1 | CC(C)[C@H](NC(=O)[C@H](CCC(=O)O[Si](C)(C)C)N[Si](C)(C)C)C(=O)O[Si](C)(C)C | 2168.6 | Semi standard non polar | 33892256 | | Glutamylvaline,3TMS,isomer #1 | CC(C)[C@H](NC(=O)[C@H](CCC(=O)O[Si](C)(C)C)N[Si](C)(C)C)C(=O)O[Si](C)(C)C | 2149.1 | Standard non polar | 33892256 | | Glutamylvaline,3TMS,isomer #2 | CC(C)[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)[C@@H](N)CCC(=O)O[Si](C)(C)C)[Si](C)(C)C | 2073.6 | Semi standard non polar | 33892256 | | Glutamylvaline,3TMS,isomer #2 | CC(C)[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)[C@@H](N)CCC(=O)O[Si](C)(C)C)[Si](C)(C)C | 2135.2 | Standard non polar | 33892256 | | Glutamylvaline,3TMS,isomer #3 | CC(C)[C@@H](C(=O)O)N(C(=O)[C@H](CCC(=O)O[Si](C)(C)C)N[Si](C)(C)C)[Si](C)(C)C | 2109.1 | Semi standard non polar | 33892256 | | Glutamylvaline,3TMS,isomer #3 | CC(C)[C@@H](C(=O)O)N(C(=O)[C@H](CCC(=O)O[Si](C)(C)C)N[Si](C)(C)C)[Si](C)(C)C | 2193.3 | Standard non polar | 33892256 | | Glutamylvaline,3TMS,isomer #4 | CC(C)[C@H](NC(=O)[C@H](CCC(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C)C(=O)O | 2297.8 | Semi standard non polar | 33892256 | | Glutamylvaline,3TMS,isomer #4 | CC(C)[C@H](NC(=O)[C@H](CCC(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C)C(=O)O | 2222.2 | Standard non polar | 33892256 | | Glutamylvaline,3TMS,isomer #5 | CC(C)[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)[C@H](CCC(=O)O)N[Si](C)(C)C)[Si](C)(C)C | 2139.8 | Semi standard non polar | 33892256 | | Glutamylvaline,3TMS,isomer #5 | CC(C)[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)[C@H](CCC(=O)O)N[Si](C)(C)C)[Si](C)(C)C | 2168.9 | Standard non polar | 33892256 | | Glutamylvaline,3TMS,isomer #6 | CC(C)[C@H](NC(=O)[C@H](CCC(=O)O)N([Si](C)(C)C)[Si](C)(C)C)C(=O)O[Si](C)(C)C | 2306.8 | Semi standard non polar | 33892256 | | Glutamylvaline,3TMS,isomer #6 | CC(C)[C@H](NC(=O)[C@H](CCC(=O)O)N([Si](C)(C)C)[Si](C)(C)C)C(=O)O[Si](C)(C)C | 2207.5 | Standard non polar | 33892256 | | Glutamylvaline,3TMS,isomer #7 | CC(C)[C@@H](C(=O)O)N(C(=O)[C@H](CCC(=O)O)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 2264.5 | Semi standard non polar | 33892256 | | Glutamylvaline,3TMS,isomer #7 | CC(C)[C@@H](C(=O)O)N(C(=O)[C@H](CCC(=O)O)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 2239.6 | Standard non polar | 33892256 | | Glutamylvaline,4TMS,isomer #1 | CC(C)[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)[C@H](CCC(=O)O[Si](C)(C)C)N[Si](C)(C)C)[Si](C)(C)C | 2138.1 | Semi standard non polar | 33892256 | | Glutamylvaline,4TMS,isomer #1 | CC(C)[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)[C@H](CCC(=O)O[Si](C)(C)C)N[Si](C)(C)C)[Si](C)(C)C | 2226.4 | Standard non polar | 33892256 | | Glutamylvaline,4TMS,isomer #2 | CC(C)[C@H](NC(=O)[C@H](CCC(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C)C(=O)O[Si](C)(C)C | 2279.7 | Semi standard non polar | 33892256 | | Glutamylvaline,4TMS,isomer #2 | CC(C)[C@H](NC(=O)[C@H](CCC(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C)C(=O)O[Si](C)(C)C | 2270.6 | Standard non polar | 33892256 | | Glutamylvaline,4TMS,isomer #3 | CC(C)[C@@H](C(=O)O)N(C(=O)[C@H](CCC(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 2278.9 | Semi standard non polar | 33892256 | | Glutamylvaline,4TMS,isomer #3 | CC(C)[C@@H](C(=O)O)N(C(=O)[C@H](CCC(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 2307.9 | Standard non polar | 33892256 | | Glutamylvaline,4TMS,isomer #4 | CC(C)[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)[C@H](CCC(=O)O)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 2306.1 | Semi standard non polar | 33892256 | | Glutamylvaline,4TMS,isomer #4 | CC(C)[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)[C@H](CCC(=O)O)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 2285.7 | Standard non polar | 33892256 | | Glutamylvaline,5TMS,isomer #1 | CC(C)[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)[C@H](CCC(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 2330.2 | Semi standard non polar | 33892256 | | Glutamylvaline,5TMS,isomer #1 | CC(C)[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)[C@H](CCC(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 2344.4 | Standard non polar | 33892256 | | Glutamylvaline,1TBDMS,isomer #1 | CC(C)[C@H](NC(=O)[C@@H](N)CCC(=O)O[Si](C)(C)C(C)(C)C)C(=O)O | 2351.1 | Semi standard non polar | 33892256 | | Glutamylvaline,1TBDMS,isomer #2 | CC(C)[C@H](NC(=O)[C@@H](N)CCC(=O)O)C(=O)O[Si](C)(C)C(C)(C)C | 2337.7 | Semi standard non polar | 33892256 | | Glutamylvaline,1TBDMS,isomer #3 | CC(C)[C@H](NC(=O)[C@H](CCC(=O)O)N[Si](C)(C)C(C)(C)C)C(=O)O | 2369.0 | Semi standard non polar | 33892256 | | Glutamylvaline,1TBDMS,isomer #4 | CC(C)[C@@H](C(=O)O)N(C(=O)[C@@H](N)CCC(=O)O)[Si](C)(C)C(C)(C)C | 2305.7 | Semi standard non polar | 33892256 | | Glutamylvaline,2TBDMS,isomer #1 | CC(C)[C@H](NC(=O)[C@@H](N)CCC(=O)O[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2555.6 | Semi standard non polar | 33892256 | | Glutamylvaline,2TBDMS,isomer #2 | CC(C)[C@H](NC(=O)[C@H](CCC(=O)O[Si](C)(C)C(C)(C)C)N[Si](C)(C)C(C)(C)C)C(=O)O | 2605.6 | Semi standard non polar | 33892256 | | Glutamylvaline,2TBDMS,isomer #3 | CC(C)[C@@H](C(=O)O)N(C(=O)[C@@H](N)CCC(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2527.8 | Semi standard non polar | 33892256 | | Glutamylvaline,2TBDMS,isomer #4 | CC(C)[C@H](NC(=O)[C@H](CCC(=O)O)N[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2588.8 | Semi standard non polar | 33892256 | | Glutamylvaline,2TBDMS,isomer #5 | CC(C)[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)[C@@H](N)CCC(=O)O)[Si](C)(C)C(C)(C)C | 2532.4 | Semi standard non polar | 33892256 | | Glutamylvaline,2TBDMS,isomer #6 | CC(C)[C@@H](C(=O)O)N(C(=O)[C@H](CCC(=O)O)N[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2587.1 | Semi standard non polar | 33892256 | | Glutamylvaline,2TBDMS,isomer #7 | CC(C)[C@H](NC(=O)[C@H](CCC(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O | 2697.2 | Semi standard non polar | 33892256 | | Glutamylvaline,3TBDMS,isomer #1 | CC(C)[C@H](NC(=O)[C@H](CCC(=O)O[Si](C)(C)C(C)(C)C)N[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2805.1 | Semi standard non polar | 33892256 | | Glutamylvaline,3TBDMS,isomer #1 | CC(C)[C@H](NC(=O)[C@H](CCC(=O)O[Si](C)(C)C(C)(C)C)N[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2685.3 | Standard non polar | 33892256 | | Glutamylvaline,3TBDMS,isomer #2 | CC(C)[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)[C@@H](N)CCC(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2748.8 | Semi standard non polar | 33892256 | | Glutamylvaline,3TBDMS,isomer #2 | CC(C)[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)[C@@H](N)CCC(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2682.2 | Standard non polar | 33892256 | | Glutamylvaline,3TBDMS,isomer #3 | CC(C)[C@@H](C(=O)O)N(C(=O)[C@H](CCC(=O)O[Si](C)(C)C(C)(C)C)N[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2817.2 | Semi standard non polar | 33892256 | | Glutamylvaline,3TBDMS,isomer #3 | CC(C)[C@@H](C(=O)O)N(C(=O)[C@H](CCC(=O)O[Si](C)(C)C(C)(C)C)N[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2694.5 | Standard non polar | 33892256 | | Glutamylvaline,3TBDMS,isomer #4 | CC(C)[C@H](NC(=O)[C@H](CCC(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O | 2970.3 | Semi standard non polar | 33892256 | | Glutamylvaline,3TBDMS,isomer #4 | CC(C)[C@H](NC(=O)[C@H](CCC(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O | 2740.8 | Standard non polar | 33892256 | | Glutamylvaline,3TBDMS,isomer #5 | CC(C)[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)[C@H](CCC(=O)O)N[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2810.0 | Semi standard non polar | 33892256 | | Glutamylvaline,3TBDMS,isomer #5 | CC(C)[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)[C@H](CCC(=O)O)N[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2668.8 | Standard non polar | 33892256 | | Glutamylvaline,3TBDMS,isomer #6 | CC(C)[C@H](NC(=O)[C@H](CCC(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2951.5 | Semi standard non polar | 33892256 | | Glutamylvaline,3TBDMS,isomer #6 | CC(C)[C@H](NC(=O)[C@H](CCC(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2706.2 | Standard non polar | 33892256 | | Glutamylvaline,3TBDMS,isomer #7 | CC(C)[C@@H](C(=O)O)N(C(=O)[C@H](CCC(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2943.0 | Semi standard non polar | 33892256 | | Glutamylvaline,3TBDMS,isomer #7 | CC(C)[C@@H](C(=O)O)N(C(=O)[C@H](CCC(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2719.4 | Standard non polar | 33892256 | | Glutamylvaline,4TBDMS,isomer #1 | CC(C)[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)[C@H](CCC(=O)O[Si](C)(C)C(C)(C)C)N[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3009.8 | Semi standard non polar | 33892256 | | Glutamylvaline,4TBDMS,isomer #1 | CC(C)[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)[C@H](CCC(=O)O[Si](C)(C)C(C)(C)C)N[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2894.3 | Standard non polar | 33892256 | | Glutamylvaline,4TBDMS,isomer #2 | CC(C)[C@H](NC(=O)[C@H](CCC(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 3179.2 | Semi standard non polar | 33892256 | | Glutamylvaline,4TBDMS,isomer #2 | CC(C)[C@H](NC(=O)[C@H](CCC(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2935.3 | Standard non polar | 33892256 | | Glutamylvaline,4TBDMS,isomer #3 | CC(C)[C@@H](C(=O)O)N(C(=O)[C@H](CCC(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3177.5 | Semi standard non polar | 33892256 | | Glutamylvaline,4TBDMS,isomer #3 | CC(C)[C@@H](C(=O)O)N(C(=O)[C@H](CCC(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2959.4 | Standard non polar | 33892256 | | Glutamylvaline,4TBDMS,isomer #4 | CC(C)[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)[C@H](CCC(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3170.3 | Semi standard non polar | 33892256 | | Glutamylvaline,4TBDMS,isomer #4 | CC(C)[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)[C@H](CCC(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2938.7 | Standard non polar | 33892256 | | Glutamylvaline,5TBDMS,isomer #1 | CC(C)[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)[C@H](CCC(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3407.0 | Semi standard non polar | 33892256 | | Glutamylvaline,5TBDMS,isomer #1 | CC(C)[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)[C@H](CCC(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3161.6 | Standard non polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Glutamylvaline GC-MS (Non-derivatized) - 70eV, Positive | splash10-0udi-5910000000-dd206506b861529c598a | 2017-09-20 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Glutamylvaline GC-MS (2 TMS) - 70eV, Positive | splash10-00di-7932000000-595f11ef6b35decd47d8 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Glutamylvaline GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glutamylvaline 10V, Positive-QTOF | splash10-0fb9-0390000000-fc60f6b4840884b6e83b | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glutamylvaline 20V, Positive-QTOF | splash10-0uki-9730000000-5f2ae69e6f8b9b6f1dec | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glutamylvaline 40V, Positive-QTOF | splash10-0a4i-9100000000-7fd20ef70cf9ada32371 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glutamylvaline 10V, Negative-QTOF | splash10-0f6t-0190000000-c60caad92d79605d6dbd | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glutamylvaline 20V, Negative-QTOF | splash10-0fvj-2980000000-10ae3625f985d16042df | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glutamylvaline 40V, Negative-QTOF | splash10-01ba-8900000000-f1ca76cd02d3da89f5ad | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glutamylvaline 10V, Positive-QTOF | splash10-015a-1960000000-f9006730da0729f9edc1 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glutamylvaline 20V, Positive-QTOF | splash10-0ue9-4900000000-c37cd1f5d5d59f336494 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glutamylvaline 40V, Positive-QTOF | splash10-0a4i-9100000000-5b26ce5e030ae3c3279b | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glutamylvaline 10V, Negative-QTOF | splash10-0002-0290000000-db6b00543f1b7512cb99 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glutamylvaline 20V, Negative-QTOF | splash10-004i-1900000000-8425065a485b241e2404 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glutamylvaline 40V, Negative-QTOF | splash10-0006-9500000000-e7692717f665a97bc5af | 2021-10-12 | Wishart Lab | View Spectrum |
NMR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum |
|
|---|
| Disease References | | Colorectal cancer |
|---|
- Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016. [PubMed:27015276 ]
- Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18. [PubMed:25037050 ]
|
|
|---|
| General References | - Jandke J, Spiteller G: Dipeptide analysis in human urine. J Chromatogr. 1986 Oct 31;382:39-45. [PubMed:3782411 ]
- Sovago I, Farkas E, Bertalan C, Lebkiri A, Kowalik-Jankowska T, Kozlowski H: Copper(II) complexes of dipeptides containing aspartyl, glutamyl, and histidyl residues in the side chain. J Inorg Biochem. 1993 Sep;51(4):715-26. [PubMed:7902418 ]
- Kanazawa A, Kakimoto Y, Nakajima T, Sano I: Identification of gamma-glutamylserine, gamma-glutamylalanine, gamma-glutamylvaline and S-methylglutathione of bovine brain. Biochim Biophys Acta. 1965 Nov 15;111(1):90-5. [PubMed:5867340 ]
- Schmugge M, Waye JS, Basran RK, Zurbriggen K, Frischknecht H: THE Hb S/beta+ -thalassemia phenotype demonstrates that the IVS-I (-2) (A>C) mutation is a mild beta-thalassemia allele. Hemoglobin. 2008;32(3):303-7. doi: 10.1080/03630260802004459. [PubMed:18473247 ]
- Suzuki H, Kato K, Kumagai H: Enzymatic synthesis of gamma-glutamylvaline to improve the bitter taste of valine. J Agric Food Chem. 2004 Feb 11;52(3):577-80. [PubMed:14759151 ]
- Frischknecht H, Troxler H, Greiner J, Hengartner H, Dutly F: Compound heterozygosity for Hb S [beta6(A3)GluVal, GAG-->GTG] and a new thalassemic mutation [beta132(H10)Lys-->term, AAA-->TAA] detected in a family from West Africa. Hemoglobin. 2008;32(3):309-13. doi: 10.1080/03630260701758866. [PubMed:18473248 ]
|
|---|